ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03737643
Brief Title: Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients. (DUO-O)

First Submitted : October 15, 2018
First Submitted that Met QC Criteria : November 8, 2018
First Posted : November 9, 2018

Last Update Submitted that Met QC Criteria : February 6, 2019
Last Update Posted : February 7, 2019